Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
91%
Monoclonal Antibody
83%
Antibody Response
41%
mRNA Vaccine
41%
Kidney Graft
41%
SARS Coronavirus
41%
Liver Transplantation
41%
Hepatitis A
41%
Sequela
41%
COVID-19 Vaccine
41%
Herpes Simplex Virus 2
41%
Virus Infection
41%
Health System
41%
Liver Graft
25%
Methylprednisolone
20%
Herpes Simplex Virus
20%
Systemic Lupus Erythematosus
20%
Prednisone
20%
Deterioration
20%
Antibody
20%
Delayed Diagnosis
20%
Abdominal Discomfort
20%
Aciclovir
20%
Therapy Delay
20%
Thorax Pain
20%
Mortality Rate
20%
Hydroxychloroquine
20%
Acute Liver Failure
20%
Infection
18%
Retrospective Cohort Study
18%
Organ Donor
16%
Overall Survival
16%
Virus Transmission
16%
Virus
12%
Transplantation
11%
Malaise
10%
Anxiety Disorder
10%
Cognitive Defect
10%
Coughing
10%
Sleep Disorder
10%
Electronic Patient Record
10%
Headache
10%
Logistic Regression Analysis
10%
Palpitation
10%
Dyspnea
10%
Pandemic
10%
Public Health
10%
Program Effectiveness
10%
Diseases
8%
Keyphrases
Neutralizing Monoclonal Antibody
52%
COVID-19
48%
Single Center
41%
Social Determinants of Health (SDoH)
41%
Anti-SARS-CoV-2 Monoclonal Antibodies
41%
Post-acute Sequelae of SARS-CoV-2
41%
Human Case
41%
Monoclonal Antibody
41%
Liver Transplantation
41%
Disease Risk
41%
Social Determinants
41%
Outpatient Treatment
41%
Respiratory Infection
41%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
41%
Coronavirus Disease (COVID)
41%
White Blood Cell Scintigraphy
41%
SAPS II
41%
Odds Ratio
41%
COVID-19 Infection
41%
Infection Outcome
41%
Hospitalization
32%
Poor Outcome
22%
Hepatitis in Pregnancy
20%
Health Variables
20%
Omicron BA.1
20%
Promising Practices
20%
Institutional Responses
13%
Rural Texas
13%
Anthrax Toxin
13%
Liver Graft
12%
Non-associated
11%
COVID-19 Outcomes
10%
Post-acute Sequelae of SARS-CoV-2 Infection
10%
Estimated Likelihood
10%
Network Database
10%
International Research Networks
10%
Area Deprivation Index
10%
Treatment Efficacy
10%
Risk Reduction
10%
Emergency Department Visits
10%
Hospitalization Risk
10%
Marginal Structural Models
8%
Health Systems
8%
Emergency Use Authorization
8%
High Risk
8%
Grafting from
8%
Viral Transmission
8%
Epidemiological Study
8%
Overall Survival
8%
Deceased Donor
8%
Pharmacology, Toxicology and Pharmaceutical Science
Monoclonal Antibody
83%
Respiratory Virus
83%
Infection
52%
Diseases
49%
SARS Coronavirus
46%
Gram Negative Sepsis
41%
Social Determinants of Health
41%
Virus Infection
41%
Overall Survival
20%
Virus Transmission
20%
Cohort Study
15%
Pandemic
10%
Combination Therapy
9%
Respiratory Tract
7%
Escherichia coli
5%
Antibiotics
5%
Immunocompromised Patient
5%
Delta Variant
5%
Adverse Outcome
5%
Adverse Drug Reaction
5%